Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Feng Zhang (China, 1981) es un neurocientífico especializado en optogenética y biología de síntesis, que investiga sobre herramientas de edición del ADN y su aplicación al tratamiento futuro de enfermedades psiquiátricas.

  2. Zhang is a molecular biologist developing and applying novel molecular technologies for studying the brain. Zhang pioneered the development of genome editing tools for use in eukaryotic cells – including human cells – from natural microbial CRISPR-Cas9 systems.

  3. en.wikipedia.org › wiki › Feng_ZhangFeng Zhang - Wikipedia

    Feng Zhang (Chinese: 张锋; pinyin: Zhāng Fēng; born October 22, 1981) is a Chinese–American biochemist. Zhang currently holds the James and Patricia Poitras Professorship in Neuroscience at the McGovern Institute for Brain Research and in the departments of Brain and Cognitive Sciences and Biological Engineering at the ...

    • American
  4. 2009. Driving fast-spiking cells induces gamma rhythm and controls sensory responses. JA Cardin, M Carlén, K Meletis, U Knoblich, F Zhang, K Deisseroth, ... Nature 459 (7247), 663-667.

  5. Biography. Feng Zhang is a McGovern Investigator, the James and Patricia Poitras Professor of Neuroscience at MIT and a professor in MIT’s Departments of Brain and Cognitive Sciences and of Biological Engineering. He is also a core member of the Broad Institute of MIT and Harvard and an Investigator at the Howard Hughes Medical Institute.

    • Feng Zhang1
    • Feng Zhang2
    • Feng Zhang3
    • Feng Zhang4
    • Feng Zhang5
  6. 28 de jun. de 2023 · Image courtesy of the Zhang lab. A team of researchers led by Feng Zhang at the McGovern Institute for Brain Research at MIT and the Broad Institute of MIT and Harvard has uncovered the first programmable RNA-guided system in eukaryotes — organisms that include fungi, plants, and animals.

  7. Dr. Zhang is a molecular biologist focused on improving human health. He played an integral role in the development of two revolutionary technologies, optogenetics and CRISPR-Cas systems, including pioneering the use of Cas9 for genome editing and discovering CRISPR-Cas12 and Cas13 systems and developing them for therapeutic and diagnostic ...